Catalent Oral Content
-
Using Zydis® ODT To Solve Delivery Challenges For Tolerogenic Vaccines
Learn about the advantages offered by the freeze dried Zydis ODT relating to large molecule storage, aggregation, and in some cases, protease activity.
-
HPAPI Drug Product Development And Manufacturing Using Micronization Technology
Learn how to classify HPAPIs in early development and recommendations for safe product handling, from clinical manufacturing to commercialization.
-
Patient-Centric Solutions To Optimize Medication Adherence
Explore how orally disintegrating tablets act as a patient-centric solution to various factors that impact treatment adherence rates across various diseases.
-
Optimizing Formulations With Bioavailability Enhancement Technologies
API-sparing development techniques and identification of the appropriate scalable formulation technology to improve drug solubility and enhance oral bioavailability can help increase your chances of success.
-
Trends In Manufacturing Of Specialty Products
Explore the challenges of producing painkillers with abuse-deterrent formulations, tips for minimizing risk during HPAPI manufacture, and how to plan for successful technology transfer.
-
Dosage Form Optimization For Patient-Centric Drug Development Process
In designing products with patients in mind by utilizing superior formulation and drug delivery technologies in the early phases of development, pharmaceutical companies can minimize risks on the path to market.
-
Designing Complex Release Oral Solids
Learn how controlled and modified release can provide improved compliance and therapeutic effectiveness with right release profile based on API properties, PK challenges, and patient needs.
-
Pediatric Patient Considerations During Dose Development
Specific dosing guidelines and acceptable dosage forms for pediatric patients need to be developed to optimize therapeutic efficacy and limit and prevent serious adverse side effects.